Axis Scores Docs In D&O Coverage Fight With BioChemics

Law360, New York (August 9, 2013, 3:59 PM EDT) -- Axis Reinsurance Co. will be able to delve into BioChemics Inc.'s communications with the U.S. Securities and Exchange Commission after a Massachusetts federal judge on Wednesday cleared the way for discovery in a suit over directors and officers coverage for an SEC enforcement action.

In her order, U.S. District Judge Rya Zobel held that Axis was entitled to discovery because the extrinsic evidence it sought was irrelevant to the merits of the SEC's enforcement action against BioChemics and John Masiz, its president and CEO.

She held...
To view the full article, register now.